Current Issue

Pharmaceutical Technology: Apr 02, 2015
Big service providers get bigger faster thanks to Big Pharma.
Pharmaceutical Technology: Apr 02, 2015
Hope abounds for local drug discovery companies despite challenges at home.
Pharmaceutical Technology: Apr 02, 2015
More reliable operations would accelerate product development and prevent drug shortages.
Pharmaceutical Technology: Apr 02, 2015
FDA approves a biosimilar and loses a commissioner in March.
Pharmaceutical Technology: Apr 02, 2015
New legislation and changes in policy at FDA are leading to better control of the API supply chain.
Pharmaceutical Technology: Apr 02, 2015
Process design experimental data and risk assessments are used to predict expected process performance and establish process performance qualification acceptance criteria.
Pharmaceutical Technology: Apr 02, 2015
In this article, industry experts discuss critical analyses for demonstrating biosimilarity.
Pharmaceutical Technology: Apr 02, 2015
The Human Microbiome Project has increased our understanding of the relationship between humans and microorganisms. The authors offer a new perspective on how this knowledge should be considered in setting standards for pharmaceutical quality control in microbiology.
Pharmaceutical Technology: Apr 02, 2015
Emerging controlled-release technologies could lead to more effective therapies in the near future.
Pharmaceutical Technology: Apr 02, 2015
Drug developers understand the importance of early communication with regulators, but is EMA providing enough flexibility and support to companies?